Herb Cross

Insider Reports History

Entity
Individual
Location
3061 Zanker Rd, San Jose, CA
Signature
/s/ Herb Cross
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Herb Cross:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Atreca, Inc. Chief Financial Officer Class A Common Stock 72.8K $29.3K $0.40 Aug 2, 2023 Direct
Jasper Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 40K Feb 15, 2024 Direct
Apexigen, Inc. Director Stock Option (right to buy) 0 Aug 23, 2023 Direct

Insider Reports Filed by Herb Cross

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JSPR Jasper Therapeutics, Inc. Feb 15, 2024 1 $0 4 Feb 20, 2024 Chief Financial Officer
JSPR Jasper Therapeutics, Inc. Sep 22, 2023 1 $0 4 Sep 26, 2023 Chief Financial Officer
JSPR Jasper Therapeutics, Inc. Sep 22, 2023 0 $0 3 Sep 26, 2023 Chief Financial Officer
APGN Apexigen, Inc. Aug 23, 2023 2 $0 4 Aug 25, 2023 Director
BCEL Atreca, Inc. Aug 2, 2023 1 -$5.22K 4 Aug 4, 2023 Chief Financial Officer
BCEL Atreca, Inc. Feb 9, 2023 2 $0 4 Feb 13, 2023 Chief Financial Officer
APGN Apexigen, Inc. Sep 29, 2022 1 $0 4 Oct 3, 2022 Director
BCEL Atreca, Inc. Sep 2, 2022 1 -$13.6K 4 Sep 20, 2022 Chief Financial Officer
APGN Apexigen, Inc. Jul 29, 2022 0 $0 3 Aug 8, 2022 Director
BCEL Atreca, Inc. Jun 13, 2022 6 $0 4 Jun 15, 2022 Chief Financial Officer
BCEL Atreca, Inc. Dec 23, 2021 1 $0 4 Dec 28, 2021 Chief Financial Officer
BCEL Atreca, Inc. Sep 9, 2021 1 $0 4 Sep 13, 2021 Chief Financial Officer